AFLIBERCEPT IN COMBINATION WITH DOCETAXEL FOR SECOND-LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC): FINAL RESULTS OF A MULTINATIONAL PLACEBO-CONTROLLED PHASE III TRIAL (EFC10261-VITAL)
Makaleler > Özet · 2011
Yazarlar: Silvia NOVELLO, Rodryg RAMLAU, Vera A. GORBUNOVA, Tudor E. CIULEANU, Mustafa Ozguroglu, Tuncay GÖKSEL, Clarissa BALDOTTO, Jaafar BENNOUNA, Frances A. Shepherd, Giorgio SCAGLIOTTI
JOURNAL OF THORACIC ONCOLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2011, cilt 6